Virological Response of Daclatasvir Plus Sofosbuvir for HCV Virological Response of Daclatasvir Plus Sofosbuvir for HCV
The results of this study support a regimen of daclatasvir plus sofosbuvir, with or without ribavirin, in patients with chronic HCV infection, including those with severe liver disease.Gut
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Gastroenterology | Health | Liver | Liver Disease | Study | Urology & Nephrology | Virology